FDMT - 4D Molecular Therapeutics  - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

FDMT is currently covered by 7 analysts with an average price target of $46.88. This is a potential upside of $20.63 (78.59%) from yesterday's end of day stock price of $26.25.

4D Molecular Therapeutics 's activity chart (see below) currently has 4 price targets and 30 ratings on display. The stock rating distribution of FDMT is 85.19% BUY and 14.81% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 47.62% with an average time for these price targets to be met of 88.43 days.

Highest price target for FDMT is $81, Lowest price target is $24, average price target is $46.88.

Most recent stock forecast was given by KOSTAS BILIOURIS from BMO on 01-Apr-2024. First documented stock forecast 05-Jan-2021.

Currently out of the existing stock ratings of FDMT, 23 are a BUY (85.19%), 4 are a HOLD (14.81%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

63

$34.25 (119.13%)

70

15 days ago

0/3 (0%)

$32.99 (109.93%)

Buy

36

$7.25 (25.22%)

36

1 months 15 days ago

0/10 (0%)

$6.63 (22.57%)

Buy

81

$52.25 (181.74%)

68

2 months 9 days ago

0/2 (0%)

$52.76 (186.83%)

Buy

35

$6.25 (21.74%)

25

2 months 11 days ago

2/2 (100%)

$2.71 (8.39%)

29

Buy

32

$3.25 (11.30%)

40

5 months 23 days ago

1/3 (33.33%)

$21.48 (204.18%)

104

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FDMT (4D Molecular Therapeutics ) average time for price targets to be met?

On average it took 88.43 days on average for the stock forecasts to be realized with a an average price target met ratio 47.62

Which analyst has the current highest performing score on FDMT (4D Molecular Therapeutics ) with a proven track record?

GEULAH LIVSHITS

Which analyst has the current lower performing score on FDMT (4D Molecular Therapeutics ) with a proven track record?

SALVEEN RICHTER

Which analyst has the most public recommendations on FDMT (4D Molecular Therapeutics )?

Geulah Livshits works at CHARDAN CAPITAL and has 6 price targets and 9 ratings on FDMT

Which analyst is the currently most bullish on FDMT (4D Molecular Therapeutics )?

Salveen Richter with highest potential upside - $52.25

Which analyst is the currently most reserved on FDMT (4D Molecular Therapeutics )?

Mani Foroohar with lowest potential downside - -$4.75

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?